BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14645881)

  • 21. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
    Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
    Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
    Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
    Yamamoto T; Kadoya N; Morishita Y; Sato Y; Matsushita H; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Jingu K
    PLoS One; 2018; 13(10):e0204734. PubMed ID: 30286105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT.
    Takeda T; Takeda A; Kunieda E; Ishizaka A; Takemasa K; Shimada K; Yamamoto S; Shigematsu N; Kawaguchi O; Fukada J; Ohashi T; Kuribayashi S; Kubo A
    AJR Am J Roentgenol; 2004 May; 182(5):1123-8. PubMed ID: 15100106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
    Urbanic JJ; Turrisi AT; Sharma AK; Silvestri GA; Williams TE; Vanek KN; Sherman CA
    J Thorac Oncol; 2006 Feb; 1(2):112-9. PubMed ID: 17409839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical three-dimensional conformal radiotherapy research using repeated computed tomography scans for field reduction in older non-small-cell lung cancer patients.
    Fu ZZ; Gu T; Zhang SH; Cao XY; Zhang QH; Zhang YQ; Hua HX; Yang S; Li P; Zhang Z
    Genet Mol Res; 2014 Jul; 13(3):5343-9. PubMed ID: 25078590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stereotactic body radiotherapy (SBRT)].
    Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto M; Yano S; Narita Y; Yamamoto T; Hiraoka M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):455-61. PubMed ID: 16612153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CT findings and risk factor analysis of hepatic injury induced by three-dimensional conformal radiation therapy].
    Liu Y; Chen LH; Zheng XK; Lü GS; Gong XH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):479-82. PubMed ID: 12754137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
    Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
    Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors.
    Hara R; Itami J; Kondo T; Aruga T; Uno T; Sasano N; Ohnishi K; Kiyozuka M; Fuse M; Ito M; Naoi K; Kohno Y
    Cancer; 2006 Mar; 106(6):1347-52. PubMed ID: 16475150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
    Thirion P; Holmberg O; Collins CD; O'Shea C; Moriarty M; Pomeroy M; O'Sullivan C; Buckney S; Armstrong J
    Radiother Oncol; 2004 May; 71(2):163-6. PubMed ID: 15110449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
    Bourgier C; Pichenot C; Verstraet R; El Nemr M; Heymann S; Biron B; Delaloge S; Mathieu MC; Garbay JR; Bourhis J; Taghian AG; Marsiglia H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1228-35. PubMed ID: 20932662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer.
    Kepka L; Tyc-Szczepaniak D; Bujko K
    J Thorac Oncol; 2009 Jul; 4(7):853-61. PubMed ID: 19487965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.
    Christian JA; Bedford JL; Webb S; Brada M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):735-41. PubMed ID: 17187941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.
    Chang EL; Shiu AS; Lii MF; Rhines LD; Mendel E; Mahajan A; Weinberg JS; Mathews LA; Brown BW; Maor MH; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1288-94. PubMed ID: 15275711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.